Anteris Technologies expands its medical advisory board

Latest News

Anteris Technologies (ASX:AVR) has announced the appointment of Associate Professor Dion Stub of the Alfred Hospital and Monash University to its Australian medical advisory board.

Associate Professor Stub specialises in structural heart procedures, including angioplasty, aortic valve replacement (TAVI) and balloon valvuloplasty.

He has further special interests in treating myocardial infarction and cardiac arrest, particularly with interventional methods.

The company said his participation in its medical advisory board is a "welcome addition" as it continues building clinical validation for the novel DurAVR 3D single-piece transcatheter aortic heart valve system.

“We are very pleased Associate Professor Stub is joining our Australian Medical Advisory Board. His significant TAVI experience and ongoing contributions will greatly enhance our commercialisation and market development efforts in Australia,” said CEO Wayne Paterson.